The biopharmaceutical aspects of nasal mucoadhesive drug delivery
The DOI matches its Crossref record; 125 of the 131 references it cites were found in a registry or an index.
Abstract
Nasal drug administration has frequently been proposed as the most feasible alternative to parenteral injections. This is due to the high permeability of the nasal epithelium, allowing a higher molecular mass cut-off at approximately 1000 Da, and the rapid drug absorption rate with plasma drug profiles sometimes almost identical to those from intravenous injections. Despite the potential of nasal drug delivery, it has a number of limitations. In this review, the anatomy and physiology of the nasal cavity, as well as ciliary beating and mucociliary clearance as they relate to nasal drug absorption, are introduced. The rationale for nasal drug delivery and its limitations, some factors that influence nasal drug absorption, and the experimental models used in nasal drug delivery research are also reviewed. Nasal mucoadhesion as a promising method of nasal absorption enhancement is discussed, and factors that influence mucoadhesion, as well as safety of nasal mucoadhesive drug delivery systems are reviewed in detail. Nasal drug administration is presently mostly used for local therapies within the nasal cavity. Anti-allergic drugs and nasal decongestants are the most common examples. However, nasal drug administration for systemic effects has been practised since ancient times. Nasally-administered psychotropic drugs by native Americans, the use of tobacco snuffs, and nasal administration of illicit drugs such as cocaine are all well known (Illum & Davis 1992). Nowadays, the nasal cavity is being actively explored for systemic administration of other therapeutic agents, particularly peptides and proteins (Illum 1992; Edman & Bjork 1992), as well as for immunization purposes (Lemoine et al 1998). To better understand the basis for nasal drug absorption and factors that can influence it, a brief review of the anatomy and physiology of the nose is appropriate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Textbook of Medical Physiology
(1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-6-1363_2 · Cited by 9,749
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues
Peppas, N. A., & Buri, P. A. (1985) · Journal of Controlled Release · doi:10.1016/0168-3659(85)90050-1 · Cited by 710 · cited 1×
“Polyanionic polymers are preferred over polycationic polymers with regard to bioadhesiveness (Park et al 1984; Peppas 1985; Leung & Robinson 1988; Duche# ne & Ponchel 1993).”
BackgroundThe Theory and Practice of Industrial Pharmacy
Fox, S. H. (1970) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600591047 · Cited by 609
Textbook of Medical Physiology
(1956) · Journal of the American Medical Association · doi:10.1001/jama.1956.02970160079021 · Cited by 517
An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery
Smart, J. D., Kellaway, I. W., & Worthington, H. E. C. (1984) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1984.tb04377.x · Cited by 467 · cited 2×
“It has been reported that increased contact timeandappliedpressure increase the adhesiveness of a polymer (Smart et al 1984; Park & Robinson 1985; Leung & Robinson 1990).”
BackgroundWheater's Functional Histology: A Text and Colour Atlas
Young, B., O'Dowd, G., & Woodford, P. (1993) · Cited by 436
Mechanisms of Mucoadhesion of Poly(acrylic Acid) Hydrogels
Park, H., & Robinson, J. R. (1987) · Pharmaceutical Research · doi:10.1023/a:1016467219657 · Cited by 360
Evaluation of the clearance characteristics of bioadhesive systems in humans
Soane, R. J., Frier, M., Perkins, A. C., Jones, N. S., Davis, S. S., & Illum, L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00367-6 · Cited by 360 · cited 1×
“Substances administered intranasally are rapidly cleared from human nose, with a clearance half-life of approximately 21 min (Soane et al 1999).”
BackgroundAnatomy, physiology and function of the nasal cavities in health and disease
Mygind, N., & Dahl, R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00058-6 · Cited by 344 · cited 1×
“The basal cells subsequently differentiate to form other epithelial cell types and are also believed to help the columnar cells adhere to the basement membrane (Mygind & Dahl 1998).”
Background
Research works printed but not linked: 19
- Arnaud, 1993, Enhancers of gastrointestinal tract, 15
- Baroody, 1999, Anatomy and physiology, 1
- Burkitt, 1993, Wheater's Functional Histology
- Chien, 1995, Biopharmaceutics basis for transmucosal delivery. S.T.P, Pharma. Sci., 5, 257
- Illum, 1992, Nasal delivery of peptides, factors affecting nasal absorption, 71
- Illum, 1992, Microspheres for nasal administration, 125
- Kamath, 1994, Mucosal adhesive preparations, 133
- Lindberg, 1997, Mucociliary transport, 155
- Longer, 1986, Fundamental aspects of bioadhesion, Pharm. Int., 5, 114
- Petri, 1985, Development of metered-dose nebulizer for intranasal peptide administration, 161
- Proctor, 1977, The upper airways I. Nasal physiology and defence of the lungs, Am. Rev. Respir. Dis., 115, 97
- Rice, 1978, The microbiology of parasinus infections: diagnosis and treatment, CRC Crit. Rev. Clin. Lab. Sci., 9, 105
- Ridley, 1992, Drug delivery to the buccal and nasal cavities, anatomical and physiological considerations, 29
- Sanders, 1997, The deposition of solution-based and suspension-based aerosols from metered dose inhalers in healthy subjects and asthmatic patients, S. T. P. Pharma Sci., 7, 300
- Satir, 1985, Switching mechanisms in control of ciliary motility, Mod. Cell Biol., 4, 1
- Sciarra, 1986, Pharmaceutical aerosols, 589
- Sciarra, 1990, Aerosols, 1694
- Tobyn, 1996, Factors affecting in vitro gastric mucoadhesion II. Properties of polymer, Eur. J. Pharm. Biopharm., 42, 56
- Ugwoke, 1999, Development and Evaluation of Controlled Release Nasal Drug Delivery Systems of Apomorphine
Cited by
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
Agrawal, M., Saraf, S., Saraf, S., Antimisiaris, S. G., Chougule, M. B., Shoyele, S. A., & Alexander, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.011 · Cited by 630
“The use of a suitable mucoadhesive system (like viscous formulation, mucoadhesive polymers, hydrogel, in situ gelations) improves the retention time and reduces the mucociliary clearance [88].”
BackgroundNasal mucoadhesive drug delivery: Background, applications, trends and future perspectives
UGWOKE, M., AGU, R., VERBEKE, N., & KINGET, R. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.009 · Cited by 543
Self-citationVasvani, S., Kulkarni, P., & Rawtani, D. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.066 · Cited by 473
Intranasal nanoemulsion based brain targeting drug delivery system of risperidone
Kumar, M., Misra, A., Babbar, A. K., Mishra, A. K., Mishra, P., & Pathak, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.029 · Cited by 435
“The formulation should be designed so as to provide a rapid transport of drug across nasal mucosa and a longer residence time in nasal cavity to overcome the nasal mucociliary clearance (Ugwoke et al., 2001).”
Metadata
- Authors
- Ugwoke, M. I., Verbeke, N., & Kinget, R.
- Affiliations
- KU Leuven (BE)
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01-01
- Volume
- 53
- Issue
- 1
- Pages
- 3-21
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W1969948087
- Cited by
- 355
- References
- 131
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 17 · 2023: 19 · 2022: 18 · 2021: 9 · 2020: 18 · 2019: 11 · 2018: 19 · 2017: 9 · 2016: 14 · 2015: 13 · 2014: 13 · 2013: 15 · 2012: 17
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Pharmacy and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Keywords
- intranasal drug delivery, mucoadhesion, nasal absorption, ciliary beating, mucociliary clearance, systemic drug administration, antiallergic drugs, nasal decongestants, protein and peptide delivery, intranasal immunization
- MeSH terms
- Administration, Intranasal, Animals, Binding Sites, Dogs, Humans, Mucous Membrane, Nasal Cavity, Permeability, Rabbits, Drug Delivery Systems, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The biopharmaceutical aspects of nasal mucoadhesive drug delivery. https://app.cochat.ai/papers/10.1211/0022357011775145
- The paper
- Ugwoke, M. I., Verbeke, N., & Kinget, R. (2001). The biopharmaceutical aspects of nasal mucoadhesive drug delivery. Journal of Pharmacy and Pharmacology. https://doi.org/10.1211/0022357011775145
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.